Quinta-Analytica

Quinta-Analytica is a well-established, privately-held CRO with over three decades of experience, providing critical analytical and bioanalytical services to the pharmaceutical and biotech industries. Its core strength lies in its comprehensive GxP (GLP, GCP, GMP) certification, enabling it to support clients through all stages of drug development, from preclinical studies to commercial batch release. The company has strategically positioned itself in the high-growth biosimilars and complex generics market, offering specialized assays and stability programs. With a focus on Central and Eastern Europe, it serves as a key partner for both regional and global companies seeking high-quality, cost-effective development services.

Integrated suite of GxP-certified analytical and bioanalytical services, specializing in chromatographic, spectroscopic, and bioassay techniques for small molecules and biologics, with dedicated facilities for Highly Active Pharmaceutical Ingredients (HAPIs).

Operates in a fragmented but competitive CRO market, competing against large multinational firms (e.g., IQVIA, LabCorp), European mid-sized specialists, and lower-cost laboratories in Asia. Its differentiation lies in its comprehensive GxP suite, niche expertise in biosimilars and HAPIs, and its established reputation in Central and Eastern Europe.